Stockscreener 앱 받기
58.86
44.26%
18.06
시간 외 거래:
59.48
0.62
+1.05%
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Eton Pharmaceuticals Stock Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Responsive Playbooks and the ETON Inflection - Stock Traders Daily
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket - Sahm
Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes - StocksToTrade
Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars After Massive Q2 Beat And Guidance Hike - timothysykes.com
Eton Pharmaceuticals Soars As Q2 Beat Triggers Aggressive Target Hikes - StocksToTrade
86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC - MarketBeat
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance? - Yahoo Finance
Why Eton Pharmaceuticals Is Top of the Class Today - The Motley Fool
Eton Pharmaceuticals Soars 39% After Earnings Beat and Upgraded Guidance - finance.biggo.com
This Analyst Believes Eton Pharma’s Raised Guidance Is ‘Conservative’ – ETON Stock Heads For Best Ever Day - Stocktwits
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ETON Stock Soars After Blowout Earnings And Guidance Hike - StocksToTrade
Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation - TechStock²
Eton Pharmaceuticals: No Reason Pharma Can't Deliver More Great Earnings Like These - Seeking Alpha
Eton Pharmaceuticals stock hits all-time high at 55.07 USD By Investing.com - Investing.com South Africa
Why is Eton Pharmaceuticals stock surging today? By Investing.com - Investing.com Canada
Eton Pharmaceuticals stock hits all-time high at 55.07 USD - Investing.com
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 1-Year High Following Earnings Beat - MarketBeat
Eton Pharmaceutical (ETON) Stock Forum and Discussion - moomoo.com
Why is Eton Pharmaceuticals stock surging today? - Investing.com
Eton Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating - marketscreener.com
Applied Industrial Technologies To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday - benzinga.com
Eton Pharmaceuticals (ETON) Stock Reprices Higher After Profit Inflection - Sahm
ETON SWOT Analysis: Financial Insights from 10-Q Filing - GuruFocus
Eton Pharmaceuticals Q2 2026 Earnings Call Transcript - MarketBeat
Eton Pharmaceuticals Q2 Earnings Call Highlights - MarketBeat
ETON PHARMACEUTICALS ($ETON) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings call transcript: Eton Pharmaceuticals tops Q2 2026 estimates, shares jump - Investing.com
Eton Pharmaceuticals, Inc. (ETON) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Eton Pharmaceuticals Q2 Results: Revenue up 99%, EBITDA margin expands to 43% - scanx.trade
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript - Benzinga
ETON: Record revenue, margin expansion, and portfolio growth drive raised 2026 guidance - TradingView
Eton Pharmaceuticals (NASDAQ:ETON) Releases Quarterly Earnings Results, Beats Expectations By $0.28 EPS - MarketBeat
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Eton Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance By Investing.com - Investing.com South Africa
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON - StreetInsider
Eton Pharmaceuticals soars 25% on earnings beat, raised guidance - Investing.com
After-Hours Movers: AMAT, DLO, GLOB, YSS, ETON By Investing.com - Investing.com Australia
Eton Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Eton Pharmaceuticals (NASDAQ: ETON) swings to H1 2026 profit on revenue jump - Stock Titan
Eton Pharmaceuticals posts Q2 2026 revenue $37.6M, GAAP EPS $0.35 and raises 2026 revenue outlook - TradingView
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-Eton Pharmaceuticals Q2 Net Income USD 11.578 Million - TradingView
Eton Now Expects 2026 Revenue to Exceed $145M After Q2 - Stock Titan
Eton Pharmaceuticals earnings ahead: Profitability in focus By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals earnings ahead: Profitability in focus - Investing.com
Equities Analysts Issue Forecasts for ETON FY2027 Earnings - MarketBeat
Wasatch Advisors LP Buys Shares of 92,742 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
What Could Eton Pharmaceuticals (ETON) Gain From The ASN 001 Licensing Deal? - Sahm
ETON PHARMACEUTICALS INC : H.C. WAINWRIGHT RAISES TARGET PRICE TO $65 FROM $57 - webull.com
Earnings To Watch: Eton Pharmaceuticals Inc (ETON) Q2 2026 -- GF Value Sees 27% Downside - Yahoo Finance
HC Wainwright Brokers Reduce Earnings Estimates for ETON - MarketBeat
Eton Pharmaceuticals Inc expected to post earnings of 11 cents a shareEarnings Preview - TradingView
Eton Pharmaceuticals (NASDAQ:ETON) Shares Down 4.5%Here's Why - MarketBeat
H.C. Wainwright raises Eton Pharmaceuticals price target to $65 By Investing.com - Investing.com Australia
H.C. Wainwright raises Eton Pharmaceuticals price target to $65 - Investing.com
Sei Investments Co. Invests $1.43 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Stock Could Be Pricey On A Very Large Three Year Run - Sahm
Eton Pharmaceuticals, Inc. $ETON Shares Sold by Renaissance Technologies LLC - MarketBeat
Eton Pharmaceuticals Inc (NASDAQ: ETON) Share Price, ETON Stock News, ETON Share Price & Updates - Kalkine
Eton Pharmaceuticals (ETON) Stock Analysis: Exploring An 18.56% Upside Potential - DirectorsTalk Interviews
0.79%
5.15%
자본화:
|
볼륨(24시간):